Literature DB >> 32619646

The IL-2 - IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor.

Jan Damoiseaux1.   

Abstract

The interleukin (IL)-2 - IL-2 receptor (IL-2R) pathway is important in immunity, but is also involved in maintenance of self-tolerance. This paradox is further complicated by shedding of the IL-2Rα chain, revealing soluble (s)IL-2R. Binding of IL-2 to sIL-2R may either reduce or enhance responses depending on the target cell being involved in immunity or self-tolerance. Since sIL-2R levels are increasingly measured in clinical practice, it is detrimental for clinical interpretation to understand the possible functional impact of IL-2R shedding. In this review the role of the IL-2 - IL-2R pathway is explored and the conflicting results on the function of sIL-2R are summarized. Finally, the added value of measuring sIL-2R in different types of diseases is being elaborated upon in terms of diagnosis, follow-up, and prognosis. Adequate interpretation of results is hampered by the apparent gap in our knowledge about the functional role of sIL-2R in immunity and tolerance.
Copyright © 2020 The Author. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD25; Immunity; Interleukin 2; Interleukin 2 receptor; Tolerance; soluble IL-2R

Year:  2020        PMID: 32619646     DOI: 10.1016/j.clim.2020.108515

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  28 in total

1.  Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.

Authors:  Andrew H Karaba; Xianming Zhu; Sarah E Benner; Olivia Akinde; Yolanda Eby; Kristy H Wang; Sharada Saraf; Jacqueline M Garonzik-Wang; Sabra L Klein; Justin R Bailey; Andrea L Cox; Joel N Blankson; Christine M Durand; Dorry L Segev; William A Werbel; Aaron A R Tobian
Journal:  Transplantation       Date:  2022-04-01       Impact factor: 4.939

2.  Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer.

Authors:  Hui Li; Miaofang Wu; Zhuna Wu; Jinxiao Liang; Lijuan Wang; Xi Yang; Zhongqiu Lin; Jing Li
Journal:  Cancer Immunol Immunother       Date:  2021-11-01       Impact factor: 6.968

3.  Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile.

Authors:  Caixia Tan; Fei Zhu; Yuanyuan Xiao; Yuqi Wu; Xiujuan Meng; Sidi Liu; Ting Liu; Siyao Chen; Juan Zhou; Chunhui Li; Anhua Wu
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

4.  Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.

Authors:  Mai Sasaki Aanensen Fraz; Annika Elisabet Michelsen; Natasha Moe; Trond Mogens Aaløkken; Magnhild Eide Macpherson; Ingvild Nordøy; Pål Aukrust; Eli Taraldsrud; Are Martin Holm; Thor Ueland; Silje Fjellgård Jørgensen; Børre Fevang
Journal:  J Clin Immunol       Date:  2022-07-05       Impact factor: 8.542

5.  Clinical significance of soluble interleukin-2 receptor measurement in patients with idiopathic retroperitoneal fibrosis.

Authors:  H H S Kharagjitsing; T R Hendriksz; M A Fouraux; T van Gelder; E F H van Bommel
Journal:  Int Urol Nephrol       Date:  2022-03-31       Impact factor: 2.266

Review 6.  Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines.

Authors:  Mirjam E Hoekstra; Saskia V Vijver; Ton N Schumacher
Journal:  Curr Opin Immunol       Date:  2021-04-13       Impact factor: 7.486

Review 7.  Interleukins in cancer: from biology to therapy.

Authors:  Daria Briukhovetska; Janina Dörr; Stefan Endres; Peter Libby; Charles A Dinarello; Sebastian Kobold
Journal:  Nat Rev Cancer       Date:  2021-06-03       Impact factor: 69.800

8.  High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.

Authors:  Aiping Ma; Liang Zhang; Xiaokai Ye; Jing Chen; Jie Yu; Liangjin Zhuang; Chaohang Weng; Frank Petersen; Zhanxiang Wang; Xinhua Yu
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

9.  Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.

Authors:  Hui Lu; Peng-Fei Wu; Wan Zhang; Xiaoyao Liao
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

10.  Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms.

Authors:  Magdalena Keindl; Olena Fedotkina; Elsa du Plessis; Ruchi Jain; Brith Bergum; Troels Mygind Jensen; Cathrine Laustrup Møller; Henrik Falhammar; Thomas Nyström; Sergiu-Bogdan Catrina; Gun Jörneskog; Leif Groop; Mats Eliasson; Björn Eliasson; Kerstin Brismar; Peter M Nilsson; Tore Julsrud Berg; Silke Appel; Valeriya Lyssenko
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-30       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.